Reckitt to sell E45 skincare brand to Karo Pharma for $268 mln – Reuters

Reckitt to sell E45 skincare brand to Karo Pharma for $268 mln – Reuters

Lysol and hand sanitizer are placed in dorms at Syracuse University as students finish out the week of classes preparing for Spring Break and an extended period of online classes due to the coronavirus outbreak at Syracuse University, New York, U.S., March 13, 2020. REUTERS/Maranie Staab

Register now for FREE unlimited access to Reuters.com

Dec 24 (Reuters) – Reckitt Benckiser (RKT.L) said on Friday it plans to sell its E45 skincare brand and related sub-brands to Karo Pharma (KARO.ST) for 200 million pounds ($267.98 million), as the British consumer goods maker shifts focus to higher growth areas.

The Durex condom and Lysol disinfectant maker said the businesses generated a combined net revenue of 43 million pounds last year.

The Slough-based company has been trimming its portfolio to concentrate on high growth categories such as disinfectants and health care products that have seen a boom during the COVID-19 pandemic. read more

Register now for FREE unlimited access to Reuters.com

In February, Reckitt sold its Scholl footcare business to private equity firm Yellow Wood Partners, and a few months later signed a deal to sell its infant formula business in China for $2.2 billion to Primavera Capital Group. read more

Reuters had reported last year that the company was preparing to sell some non-core brands and was seeking …….

Source: https://www.reuters.com/markets/deals/reckitt-sell-e45-skincare-brand-karo-pharma-268-mln-2021-12-24/

Skincare